When did Carlsmed (CARL) last report earnings?

Carlsmed last reported on Aug 5, 2026, covering fiscal Q2 2026.

Did CARL beat earnings estimates?

Yes. Carlsmed reported EPS of −$0.39 for Q2 2026 against a −$0.40 estimate — a 1.52% beat.

How much revenue did CARL report last quarter?

Carlsmed reported $18.9M in revenue for Q2 2026, against a consensus estimate of $18.0M.

Carlsmed (CARL) earnings history

Most recent quarter

Fiscal period: Q2 2026
Period end: Jun 30, 2026
EPS actual: −$0.39
EPS estimate: −$0.40
EPS surprise: +1.52%
Revenue surprise: +5.26%
Revenue: $18.9M
Revenue estimate: $18.0M
Reported: Aug 5, 2026
SEC filing: View filing
Earnings call: Transcript

Earnings history

Period	Reported	EPS estimate	EPS actual	Surprise	Revenue	Filing
Q2 2026	Aug 5, 2026	−$0.40	−$0.39	+1.52%	$18.9M	SEC
Q1 2026	May 5, 2026	−$0.38	−$0.32	+15.79%	$16.1M	SEC
Q4 2025	Feb 25, 2026	−$0.42	−$0.32	+23.76%	$15.2M	SEC
Q3 2025	Nov 6, 2025	−$0.48	−$0.40	+16.94%	$13.1M	SEC
Q2 2025	Aug 28, 2025	−$0.91	−$1.47	−60.78%	$12.1M	SEC

Quarterly revenue

Q2 2025

$12.1M

Q3 2025

$13.1M

Q4 2025

$15.2M

Q1 2026

$16.1M

Q2 2026

$18.9M

Frequently asked questions

When did Carlsmed (CARL) last report earnings?
Carlsmed last reported on Aug 5, 2026, covering fiscal Q2 2026.
Did CARL beat earnings estimates?
Yes. Carlsmed reported EPS of −$0.39 for Q2 2026 against a −$0.40 estimate — a 1.52% beat.
How much revenue did CARL report last quarter?
Carlsmed reported $18.9M in revenue for Q2 2026, against a consensus estimate of $18.0M.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by